Introduction
We are doctors looking after patients with blood disorders and scientists studying blood conditions in the lab. Our aim is to deliver the best expert and compassionate care for patients with blood diseases and patients who need blood cell transfusions. We want to reduce the burden of disease now and in the future, through our research, services, education, outreach and advocacy.
Our group includes international, scientific and clinical leaders. We draw on our combined expertise to carry out research and develop new services. Through our work we aim to:
- Improve the cost-effectiveness of cancer therapies and the outcomes of treatment – by developing new single cell approaches which tailor treatments to individuals. Find out more
- Improve the management of common and rare anaemias – by studying the role of iron and inflammation in anaemic patients, especially those who are elderly, and by developing a new national NHS service for patients with rare inherited red cell disorders. Find out more
- Improve the outcomes of blood cell and blood component transfusions – by using advanced e-tools and carrying out clinical trials to find out what approaches work best. Find out more
- Involve patients and carers in the key steps of our research projects. Find out more
Related websites
Oxford Centre for Haematology website: rdm.ox.ac.uk/och
RDM – HaemBio Biobank pages:
rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/och/haembio
NSSG website: nssg.oxford-haematology.org.uk
Introductory Talk by Haematology and Stem Cells Theme Lead Professor Paresh Vyas
Follow the Oxford Centre for Haematology on Twitter
Great meeting at a wonderful venue! Come to Oxford next year for the Lymphoma Management Course
New venue - same fantastic course with amazing faculty. Do come for a truly National overview of lymphoma management in a wonderful setting.
@WorcCollegeOx even has its own cricket pitch (& lake) which will keep @tobyeyre82 happy!
@OxfordHaem https://t.co/1YwiwgU4x6
Patients, carers and clinicians learning from each other at the non-malignant haematology event. Great evening! @oxford_blood
Learning about the fantastic resource that is the Tranfusion Evidence Library @TransfusionLib. Thanks Alicia! @oxford_blood
Surprising! Ovlisen et al - fertility rates in #Hodgkin survivors HIGHER than matched controls, 🚹&🚺
Thoughts:
- survivors less likely to use birth control as they think they are infertile?
- survivors have renewed focus on family?
Other ideas? #ASH19
https://t.co/ZHne5ZVKya
Great video lesson Nelson thanks, enjoy National #PathologyWeek @SpotLeukaemia @LeukaemiaCareUK
@UkCll @scicommchar @ZPWLC @TheChristieSoO @CCCNHS @DrAmitPatel @CllIreland @CLLAdvocates @CRGHaem @OxfordHaem @qehbham @WorcsAcuteNHS @CLLSupport @bloodwise_uk @LymphomaAction
Davidson Ateh on Twitter
“What do pathologists do? This is fantastic from my wonderful @BioMoti co-founder! #Nelsonspathologyweek #pathologyweek https://t.co/aPeSECqlBd&...
twitter.com
We’ve got some important news – we're changing our name. This follows extensive consultation with our supporters, who've told us our current name is often a barrier to people engaging with us & doesn't represent the work we do.
Read about our decision 👇
We're changing our name
We want to share the news that we will be changing our name, and tell you about the reasons that have led us to this decision.
bit.ly